Prostaglandins for induction of second-trimester termination and intrauterine death.

[1]  A. Chittacharoen,et al.  A Randomized Trial of Oral and Vaginal Misoprostol to Manage Delivery in Cases of Fetal Death , 2003, Obstetrics and gynecology.

[2]  D. Baird,et al.  A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy , 2002, BJOG : an international journal of obstetrics and gynaecology.

[3]  M. Bebbington,et al.  A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination. , 2002, American journal of obstetrics and gynecology.

[4]  P. Blumenthal,et al.  Buccal misoprostol as cervical preparation for second trimester pregnancy termination. , 2002, Contraception.

[5]  A. Templeton,et al.  Medical management of late intrauterine death using a combination of mifepristone and misoprostol , 2002, BJOG : an international journal of obstetrics and gynaecology.

[6]  S. Evans,et al.  The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination. , 2002, American journal of obstetrics and gynecology.

[7]  S. Droste,et al.  Uterine Rupture During Second‐Trimester Abortion Associated With Misoprostol , 2001, Obstetrics and gynecology.

[8]  P. Ho,et al.  Pilot study on the use of sublingual misoprostol for medical abortion. , 2001, Contraception.

[9]  P. Ho,et al.  Randomized comparison of vaginal (200 microg every 3 h) and oral (400 microg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy. , 2000, Human reproduction.

[10]  K. Gemzell‐Danielsson,et al.  Termination of second trimester pregnancy with mifepristone and gemeprost , 2000 .

[11]  K. Gemzell‐Danielsson,et al.  Termination of second trimester pregnancy with mifepristone and gemeprost. The clinical experience of 197 consecutive cases. , 2000, Acta obstetricia et gynecologica Scandinavica.

[12]  P. Ho,et al.  A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial. , 2000, Human reproduction.

[13]  J. Shih,et al.  Separation of cesarean scar during second-trimester intravaginal misoprostol abortion. , 1999, Obstetrics and gynecology.

[14]  R. W. Martin,et al.  Second-trimester uterine evacuation: A comparison of intra-amniotic (15S)-15-methyl-prostaglandin F2alpha and intravaginal misoprostol. , 1999, American journal of obstetrics and gynecology.

[15]  H. Scheepers,et al.  Use of misoprostol in first and second trimester abortion: a review. , 1999, Obstetrical & gynecological survey.

[16]  A. Templeton,et al.  Nonsurgical mid‐trimester termination of pregnancy: a review of 500 consecutive cases , 1999, British journal of obstetrics and gynaecology.

[17]  D. Grossman,et al.  A randomized controlled trial of laminaria, oral misoprostol, and vaginal misoprostol before abortion. , 1999, Obstetrics and gynecology.

[18]  D. Mishell,et al.  A comparison of two dosing regimens of intravaginal misoprostol for second-trimester pregnancy termination. , 1999, Obstetrics and gynecology.

[19]  P. Ho,et al.  Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial. , 1998, Contraception.

[20]  J. Srisomboon,et al.  Efficacy of Intracervicovaginal Misoprostol in Second‐Trimester Pregnancy Termination: A Comparison between Live and Dead Fetuses , 1998, The journal of obstetrics and gynaecology research.

[21]  Y. Herabutya,et al.  Second trimester abortion using intravaginal misoprostol , 1998, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[22]  O. Ylikorkala,et al.  A Comparison Between Two Doses of Intravaginal Misoprostol and Gemeprost for Induction of Second‐Trimester Abortion , 1997, Obstetrics and gynecology.

[23]  P. Ho,et al.  Vaginal Misoprostol Compared With Oral Misoprostol in Termination of Second‐Trimester Pregnancy , 1997, Obstetrics and gynecology.

[24]  N. Benowitz,et al.  Absorption Kinetics of Misoprostol With Oral or Vaginal Administration , 1997, Obstetrics and gynecology.

[25]  M. Crispens,et al.  Complications of midtrimester pregnancy termination: the effect of prior cesarean delivery. , 1996, American journal of obstetrics and gynecology.

[26]  P. Ho,et al.  Termination of second trimester pregnancy with gemeprost and misoprostol: a randomized double-blind placebo-controlled trial. , 1996, Contraception.

[27]  P. Ho,et al.  Misoprostol is as effective as gemeprost in termination of second trimester pregnancy when combined with mifepristone: a randomised comparative trial. , 1996, Contraception.

[28]  A. Mathers,et al.  Uterine rupture during second trimester termination of pregnancy using mifepristone and a prostaglandin. , 1996, European journal of obstetrics, gynecology, and reproductive biology.

[29]  J. Norman.  Uterine rupture during therapeutic abortion in the second trimester using mifepristone and prostaglandin , 1995, British journal of obstetrics and gynaecology.

[30]  S. Bergström,et al.  Vaginal misoprostol as an alternative to oxytocin for induction of labor in women with late fetal death , 1995, Acta obstetricia et gynecologica Scandinavica.

[31]  D. Mishell,et al.  A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy. , 1994, The New England journal of medicine.

[32]  C. Bique,et al.  Induction of labor with intravaginal misoprostol in intrauterine fetal death. , 1994, American journal of obstetrics and gynecology.

[33]  P. Kjølhede,et al.  An open prospective randomized study of dinoproston and gemeprost in second trimester legal abortions , 1994 .

[34]  D. Baird,et al.  Induction of second trimester abortion with mifepristone and gemeprost , 1993 .

[35]  D. Baird,et al.  A retrospective study of 932 second trimester terminations using gemeprost (16,16 dimethyl-trans delta 2 PGE1 methyl ester). , 1992, Prostaglandins.

[36]  E. Baulieu,et al.  Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue: Study in 16, 369 women , 1992, Acta obstetricia et gynecologica Scandinavica.

[37]  D. Baird,et al.  An open study comparing two regimens of gemeprost for the termination of pregnancy in the second trimester , 1992, Acta obstetricia et gynecologica Scandinavica.

[38]  C. Gottlieb,et al.  Vacuum aspiration for termination of early second trimester pregnancy after treatment with vaginal prostaglandin , 1991, Acta obstetricia et gynecologica Scandinavica.

[39]  J. Wiener,et al.  Uterine rupture in midtrimester abortion. A complication of gemeprost vaginal pessaries and oxytocin. Case report. , 1990, British journal of obstetrics and gynaecology.

[40]  D. Cabrol,et al.  Induction of labor with mifepristone (RU 486) in intrauterine fetal death. , 1990, American journal of obstetrics and gynecology.

[41]  A. Haspels,et al.  Late second trimester abortion with 16,16-dimethyl-trans-δ2-PGE1 methyl ester (gemeprost) , 1990 .

[42]  D. Luesley,et al.  Gemeprost vaginal pessaries for inducing third‐trimester intrauterine deaths , 1989, British journal of obstetrics and gynaecology.

[43]  N. Christensen,et al.  Development of a vaginal gel containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 for cervical dilatation and pregnancy termination. , 1988, Prostaglandins, leukotrienes, and essential fatty acids.

[44]  M. Bygdeman.  Termination of second trimester pregnancy with laminaria and intramuscular 15‐methyl PGF2α or 16‐phenoxy‐ω‐17,18,19,20‐tetranor PGE2 methylsulfonylamide. A randomized multicenter study , 1988 .

[45]  I. Cameron,et al.  Prostaglandin-induced pregnancy termination: further studies using gemeprost (16,16 dimethyl-trans-delta 2-PGE1 methyl ester) vaginal pessaries in the early second trimester. , 1987, Prostaglandins.

[46]  D. Cabrol,et al.  INDUCTION OF LABOUR WITH MIFEPRISTONE AFTER INTRAUTERINE FETAL DEATH , 1985, The Lancet.

[47]  K. Schulz,et al.  Prevention of uterine perforation during curettage abortion. , 1984, JAMA.

[48]  J. Herczeg,et al.  Termination of second trimester pregnancy by intramuscular injection of 16‐phenoxy‐ω‐17,18,19,20‐tetranor‐PGE2 methyl sulphonylamide , 1982, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[49]  R. Burkman,et al.  Midtrimester abortion induced by hyperosmolar urea and prostaglandin F2 alpha in patients with previous cesarean section: clinical course and potential for uterine rupture. , 1980, American journal of obstetrics and gynecology.

[50]  R. Nyberg,et al.  Repeated vaginal administration of 15-methyl PGF2α methyl ester for termination of pregnancy in the 13th–20th week of gestation , 1977 .

[51]  K. Wilson,et al.  Luteolytic and abortifacient effects of serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2alpha in early pregnancy. , 1976, American journal of obstetrics and gynecology.

[52]  K. Wilson,et al.  Termination of midtrimester pregnancy by serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2alpha. , 1976, American journal of obstetrics and gynecology.

[53]  N. Whitley.  Second trimester abortion. A program of counseling and teaching. , 1973, JOGN nursing; journal of obstetric, gynecologic, and neonatal nursing.

[54]  M. Bygdeman,et al.  Induction of abortion by intra-amniotic administration of prostaglandin F2α , 1971 .

[55]  W. Brenner,et al.  Efficacy and tolerance of intravenous prostaglandins F2α and E2 , 1971 .

[56]  G. Bundy,et al.  NOVEL PROSTAGLANDIN SYNTHESES , 1971, Annals of the New York Academy of Sciences.

[57]  D. Mishell,et al.  Abortifacient activity of intravenously administered prostaglandins , 1971 .

[58]  M. Bygdeman,et al.  Induction Of Abortion by the Intravenous Administration of Prostaglandin F2xA Critical Evaluation , 1971, Acta obstetricia et gynecologica Scandinavica.

[59]  M. Bygdeman,et al.  Therapeutic abortion by local administration of prostaglandin. , 1970, Lancet.

[60]  M. Bygdeman,et al.  Induction of therapeutic abortion with intravenous prostaglandin F. , 1970, Lancet.

[61]  S. Karim,et al.  THERAPEUTIC ABORTION USING PROSTAGLANDIN F2α , 1970 .

[62]  M. Bygdeman,et al.  Prostaglandins for induction of therapeutic abortion. , 1970, Lancet.

[63]  N. Sebire,et al.  The management of gestational trophoblastic neoplasia. Royal College of Obstetricians and Gynaecologists, Guideline Number 38 , 2004 .

[64]  Baird Dt.  Mode of action of medical methods of abortion. , 2000 .

[65]  M. Paul,et al.  A clinician's guide to medical and surgical abortion , 1999 .

[66]  D. Simeon,et al.  Induction of labour with intravaginal misoprostol versus dinoprostone in intrauterine death: A retrospective study , 1996 .

[67]  N. Hawkes,et al.  Induction of labour with vaginal misoprostol after intrauterine death from 24 weeks gestation , 1996 .

[68]  T. Mould,et al.  The use of gemeprost for induction of labour after intrauterine death in the third trimester , 1996 .

[69]  M. Hoffet,et al.  Late vaginal induced abortion after a previous cesarean birth: potential for uterine rupture. , 1993, Gynecologic and obstetric investigation.

[70]  I. Mackenzie,et al.  Management of intra-uterine fetal death with vaginal administration of gemeprost or prostaglandin E2: A random allocation controlled trial , 1991 .

[71]  C. Tietze.  Second-Trimester Abortion: A Global View , 1981 .